NCT04547439View on ClinicalTrials.gov

Sleep, Diabetic Retinopathy and Melatonin

PHASE2RecruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

February 3, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Diabetes MellitusDiabetic Retinopathy
Interventions
DRUG

Melatonin

Melatonin 3 mg will be taken nightly for 8 weeks

OTHER

Placebo

Placebo will be given nightly for 8 weeks

Trial Locations (1)

60612

RECRUITING

University of Illinois at Chicago, Chicago

All Listed Sponsors
collaborator

University of Chicago

OTHER

lead

University of Illinois at Chicago

OTHER